Organization · Corporate Venture Capital
Yuanta Investment Korea (유안타인베스트먼트)
Yuanta Investment Korea is a venture capital and private equity management firm based in South Korea, focusing on investments in healthcare, biotechnology, and technology sectors. It is a subsidiary of Yuanta Financial Holdings from Taiwan.
Overview
What Yuanta Investment Korea (유안타인베스트먼트) does
What Yuanta Investment Korea (유안타인베스트먼트) is
Yuanta Investment Korea is a venture capital and private equity management firm based in South Korea, focusing on investments in healthcare, biotechnology, and technology sectors. It is a subsidiary of Yuanta Financial Holdings from Taiwan.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Corporate Venture Capital
- Founded
- Founded in 1989
- Approximate age
- About 37 years
- Structured capabilities
- Funder
- Last reviewed
- May 5, 2026
Official channels
Find Yuanta Investment Korea (유안타인베스트먼트) elsewhere
Open the official website or a supported primary organization account.
Capability profile
Yuanta Investment Korea (유안타인베스트먼트) as a funder
Investment thesis
Yuanta Investment Korea aims to be a long-tenured Korean VC and private-equity manager that backs companies while leveraging Yuanta's East Asian financial network, focusing on life sciences and technology.
Focus narrative
Yuanta Investment Korea invests primarily in healthcare, biotechnology, life sciences, and technology sectors. The firm engages in various stages of investment, with a notable focus on growth and late-stage opportunities, particularly in Korean biotech and AI-enabled drug discovery.
Value beyond capital
Yuanta Investment Korea adds value to its portfolio companies by leveraging its extensive East Asian financial network, providing strategic guidance, and facilitating access to resources and expertise in the healthcare and technology sectors.
Focus and fit
- Stages
- Seed · Series A · Series B · Series C · Growth Equity
- Sectors
- HealthcareBiotech & Life SciencesArtificial IntelligenceLogistics & Supply ChainConsumerIndustrial & Manufacturing
- Regions
- East AsiaAsiaUnited States
Availability
- Currently deploying
- Yes
Portfolio and track record
Portfolio context
Notable portfolio companies include Galux, an AI-driven protein therapeutics company; Cureverse, which develops treatments for Alzheimer's disease; and Selta Square, an AI pharmacovigilance platform. Other investments include LISCure Biosciences, Rznomics, and Panmnesia, showcasing a strong emphasis on healthcare and technology.
Common questions
What to know about Yuanta Investment Korea (유안타인베스트먼트)
Upseed classifies Yuanta Investment Korea (유안타인베스트먼트) under the Corporate Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 5, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.